AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
OneMedNet shares surge 14.78% premarket as AI-ready platform validation and network expansion drive optimism.
ByAinvest
Monday, Dec 1, 2025 4:00 am ET1min read
OneMedNet (ONMD) surged 14.78% in premarket trading following the announcement of its AI-ready Real-World Data platform validation and a 380-provider site network expansion, which strengthened its position in healthcare data analytics. The company also reported an 815% year-over-year increase in Q3 bookings, driven by strategic partnerships, including a collaboration with Palantir, and a SaaS subscription model rollout. These developments, coupled with a 13 million rise in de-identified patient records and 50 million additional clinical exams, signaled operational momentum despite ongoing financial challenges. The news reinforced investor confidence in ONMD’s long-term growth potential, aligning with the stock’s upward trajectory ahead of its regular trading session.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet